The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.
Article obtained from Photonics RSS Feed.
COVID-19 antibody testing could be possible with a microfluidic device invented at the University of Michigan (U-M) and developed by U-M startup Optofluidic Bioassay. The new system is believed to be the first microfluidic approach to a gold-standard testing protocol known as “enzyme-linked immunosorbent assay,” or ELISA.
A microfluidic device, or lab-on-a-chip, shrinks multiple lab functions onto a single chip millimeters to centimeters in size. The U-M researchers have previously published results showing that their device can work as well as the standard ELISA setup. They are currently validating it for use on COVID-19 antibodies.
The researchers’ demonstrations have shown that they can detect synthetic COVID-19…READ MORE